The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Depression affects millions of people worldwide, but much is still unknown about this illness and treatments don't always ...
Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...
A novel PET imaging approach can effectively quantify a key enzyme associated with brain inflammation, according to research ...
Blue Protocol: Star Resonance, a game so far kept under wraps with three closed-door playtests, might have its open playtest soon. The game's official Bilibili page recently put out its first ...
Many already healthy individuals take the scan hoping to be reassured that nothing is out of the ordinary. But Blackburn had ...
Imaging tests: Problems with the thymus gland can be a sign of MG. A CT scan (computed tomography) or an MRI (magnetic resonance imaging) may be ordered to check for an enlarged thymus or a thymus ...
This longstanding course is designed to teach the scientific principles upon which nuclear medicine imaging is based. It gives an introduction to the underlying physics and radiochemistry principles ...
We promote and support the joint use and sustainable further development of biomedical imaging technologies at the University of Münster. All scientists at our university can use and make available ...
Medical imaging has traditionally focused on creating static visual representations of a patient's internal anatomy. This practice is essential for detecting conditions, guiding treatments and ...
Medical Imaging Corp. engages in the manufacture and sale of medical and hospital equipment. It sells products under various brand names, including Lunar, Omnipaque, Omniscan, Visipaque and Sonazoid.
Medical imaging is a broad term that encompasses several distinct technologies. After working on AI-powered tools to enhance X-rays and mammographies, French startup Gleamer now aims to tackle ...